The absence of glistening formation is among the advantages associated with new IOL technology, relates one ophthalmologist.
Recent randomized clinical trials have been advancing the understanding of current treatments for convergence insufficiency. More prospective studies are needed to investigate convergence types and their roles in convergence insufficiency.
A trifocal diffractive intraocular lens (FineVision IOL, PhysIOL) reduces spectacle dependence after cataract surgery and provides patient satisfaction.
Fibrin glue might be a potential cause of toxic anterior segment syndrome (TASS).
Phototherapeutic keratectomy (PTK) provides excellent visual outcomes in patients with irregular astigmatism and corneal opacity.
Use of imaging in clinical practice offers clinicians a number of advantages for following patients with glaucoma, perhaps most importantly the ability sometimes to detect damage before it is apparent on fundus photographs, objective rates of glaucoma progression, and the ability to predict the patients who are at high risk of functional impairment. Robert N. Weinreb, MD, talked about how imaging and clinical practice are a good fit.
Optic neuritis in juvenile neuromyelitis optica (NMO) Optic neuritis treatments vary greatly for NMO and MS
Bevacizumab (Avastin, Genentech) monotherapy for zone I retinopathy of prematurity (ROP) might have potential for treating pre-term infants who are in phase II of the pathogenesis of ROP.
A minimally invasive technique for the correction of refractive errors has good refractive predictability, is safe and effective, and has excellent stability up to 1 year postoperatively.
Intermittent diplopia often is not evident during presentation, which makes its diagnosis problematic.